Does IXAZOMIB Cause Product dose omission issue? 706 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 706 reports of Product dose omission issue have been filed in association with IXAZOMIB (NINLARO). This represents 3.2% of all adverse event reports for IXAZOMIB.
706
Reports of Product dose omission issue with IXAZOMIB
3.2%
of all IXAZOMIB reports
53
Deaths
252
Hospitalizations
How Dangerous Is Product dose omission issue From IXAZOMIB?
Of the 706 reports, 53 (7.5%) resulted in death, 252 (35.7%) required hospitalization, and 2 (0.3%) were considered life-threatening.
Is Product dose omission issue Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for IXAZOMIB. However, 706 reports have been filed with the FAERS database.
What Other Side Effects Does IXAZOMIB Cause?
Plasma cell myeloma (3,249)
Death (2,845)
Off label use (2,841)
Diarrhoea (2,560)
Pneumonia (1,583)
Nausea (1,568)
Fatigue (1,456)
Neuropathy peripheral (1,162)
Vomiting (977)
Thrombocytopenia (964)
What Other Drugs Cause Product dose omission issue?
DUPILUMAB (18,189)
USTEKINUMAB (9,405)
GUSELKUMAB (9,267)
LENALIDOMIDE (8,145)
MEPOLIZUMAB (5,873)
TOFACITINIB (5,646)
VOXELOTOR (5,122)
BELIMUMAB (4,671)
SECUKINUMAB (4,572)
APREMILAST (4,460)
Which IXAZOMIB Alternatives Have Lower Product dose omission issue Risk?
IXAZOMIB vs IXEKIZUMAB
IXAZOMIB vs JAKAFI
IXAZOMIB vs JAKAVI
IXAZOMIB vs JANUMET
IXAZOMIB vs JANUVIA